Maravai Lifesciences Holdings Inc (MRVI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.96B
Last updated: Nov 17, 2026 at 4:15 PM ET
Maravai Lifesciences Holdings Inc (MRVI) Stock Chart
Maravai Lifesciences Holdings (MRVI) has a latest price of $7.28 on Nov 17, 2026, 22.7% below its 52-week high of $9.42. Its price rose 100.0% over the past 12 months. The month-end price fell 81.5% over the 5 years through Oct 2026, a compound annual decline of 28.7%.
Price Chart
From Nov 2020 to Oct 2026, its highest month-end close was $59.18 in Aug 2021 and its lowest $2.02 in Apr 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MRVI with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MRVI.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 0.8%, and over 6 months it rose 72.5%. The month-end price rose 13.8% over the 3 years through Oct 2026, a compound annual rate of 4.4%.
| Period | Change |
|---|---|
| 1 month | +4.1% |
| 3 months | +0.8% |
| 6 months | +72.5% |
| 12 months | +100.0% |
| 12 months, with dividends | +100.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +13.8% | +4.4% |
| 5 years | -81.5% | -28.7% |
Price by Year
Its best calendar year was 2021, when the price rose 49.4%, and its weakest was 2022, when it fell 65.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $7.81 | +140.3% |
| 2025 | $3.25 | -40.4% |
| 2024 | $5.45 | -16.8% |
| 2023 | $6.55 | -54.2% |
| 2022 | $14.31 | -65.8% |
| 2021 | $41.90 | +49.4% |
Trading Range
The price is 1.6% below its 50-day average of $7.40 and 33.1% above its 200-day average of $5.47.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $7.28 | |
| 52-week high | $9.42 | -22.7% |
| 52-week low | $2.80 | +160.0% |
| 50-day average | $7.40 | -1.6% |
| 200-day average | $5.47 | +33.1% |
Price Risk
Over 3 years, its largest fall from a peak was 84.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.65 |
| Largest fall, 1 year | -29.6% |
| Largest fall, 3 years | -84.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MRVI
What is MRVI's 1-year price change?
Maravai Lifesciences Holdings's price rose 100.0% over the past 12 months. With dividends included, the 12-month total return was 100.0%.
What is MRVI's 5-year price change?
Maravai Lifesciences Holdings's month-end price fell 81.5% over the 5 years through Oct 2026, a compound annual decline of 28.7%. These figures leave out dividends.
What is MRVI's 52-week high and low?
Maravai Lifesciences Holdings's 52-week high is $9.42 and its 52-week low is $2.80. Its latest price of $7.28 on Nov 17, 2026 is 22.7% below the high.
What is MRVI's beta?
Maravai Lifesciences Holdings's 1-year beta against the S&P 500 is 1.65, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 29.6%.
Is the MRVI chart free?
Yes. Advanced Charting for MRVI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MRVI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors